First Zika Cases Reported In India; Government Says No Need For Panic
Executive Summary
WHO reports confirmation of three cases of Zika infection in the western state of Gujarat but a top Indian government official assures there’s no need for “panic” as there have been no fresh reports of the virus in months. Hyderabad-based Bharat’s Zika vaccine cleared to begin Phase I trials.
You may also be interested in...
Bharat Enters Chikungunya Fray As Vaccine Moves Into Trials
Indian vaccine developer Bharat Biotech has moved a candidate vaccine for chikungunya into Phase I trials, joining over a dozen firms worldwide hoping to commercialize the first vaccine to halt transmission of the painful mosquito-borne illness, which is spreading globally.
India’s ‘Cautious’ View Dulls Sanofi Hopes For Early Dengvaxia Launch
An early rollout of Sanofi Pasteur’s dengue vaccine in India is looking less likely with a senior functionary of the health ministry telling Scrip why India needs to take a “cautious view” on the product’s licensure in the country, at least for now. Sanofi, though, has sought the “best regulatory solution” that can facilitate access to the product.
Top US Court Lifts Discovery Stay On Price-Fixing
The US Supreme Court has lifted a stay on document discovery in a multi-state lawsuit in which dozens of generics companies – including Teva, Mylan and Pfizer – are accused of price fixing. The ruling will allow a swathe of documents to be released in what Connecticut’s attorney general has said is potentially “the largest cartel case” in US history.